Boston Scientific
  • BSX

  • $97.52

  • -0.20%
  • $97.72

  • $98.69

  • $97.02

Prices as of 2025-12-05 16:20:42 ET

Ticker Appearances

Technical Strategy
Mon, October 20, 2025 | 6:20PM ET

AAPL, GOOGL, NFLX breakouts help to aid "Mag 7" in the short run

NEAR-TERM TRENDS ARE BULLISH FOR SPX AND I ANTICIPATE A SHARP RALLY TO FINISH THE MONTH OF OCTOBER AFTER AN INTERESTING PERIOD OF SECTOR ROTATION...

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Daily Technical Strategy
Thu, July 10, 2025 | 7:23PM ET

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Daily Technical Strategy
Tue, January 21, 2025 | 7:43PM ET

Healthcare, Financials & Industrials comeback has been constructive

SPX’S TECHNICAL TREND, BREADTH, AND MOMENTUM BEGAN TO TURN MORE BULLISH LATE LAST WEEK, AND THE MOVE ABOVE SPX 6021 SUGGESTS A LIKELY PUSH TO...

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Daily Technical Strategy
Tue, May 28, 2024 | 8:12PM ET

Technology comeback continues

EQUITY TREND BULLISH BUT I SUSPECT THAT UNTIL BOTH DXY AND TNX BREAK TRENDLINE SUPPORT THE RALLY MIGHT PROVE A BIT CHOPPIER INTO THE END...

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Daily Technical Strategy
Wed, January 31, 2024 | 8:18PM ET

SPX pullback should prove short-lived;  Healthcare deserves an Overweight

SPX AND QQQ LOOK TO HAVE BEGUN MINOR PULLBACKS WITH WEDNESDAY’S DECLINE, WHICH HAPPENED DURING A SIGNIFICANT WEEK OF FOMC MEETING, “MAGNIFICENT 7” EARNINGS AS...

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Daily Technical Strategy
Thu, January 11, 2024 | 7:34PM ET

Short-term SPX Peak should be near;  DXY could strengthen into March

NEAR-TERM TRENDS LOOK TO BE TURNING DOWN FOLLOWING A TEST OF DECEMBER 2023 PEAKS ACROSS MULTIPLE US INDICES ON THURSDAY.  WEAKNESS OVER THE NEXT WEEK...

Already have an account? Sign In

Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a

Events

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In